Korea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic Arthritis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Korea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic Arthritis — Stella

Recruiting

Back to Psoriatic Arthritis, Juvenile trials

Trial locations(1 site)

South Korea

Pfizer, Seoul

Key details

Sponsor

Pfizer

Enrollment target

~10 participants

Started

April 2024

Primary completion

September 2026

Age range

2 Years – 17 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov